Golden Arrow and Silver Standard Join Forces in Argentina
Source: The Gold Report  (4/13/17)
Stars aligned for Golden Arrow when Chinchillas was ready to move to production and the company only had to look 18 miles down the road to Silver Standard's Pirquitas mine and its established production facility. More >

DNI Delivers Profitable Graphite
Source: Bob Moriarty for The Gold Report  (4/13/17)
For Bob Moriarty of 321 Gold, the boom in demand for lithium ion batteries also means a boom in demand for graphite, and he is placing his bets on a junior he believes has nothing but blue sky ahead.
More >

Gold Standard Ventures Is Building Its Portfolio with Battle Mountain Gold Acquisition
Source: The Gold Report  (4/13/17)
The purchase of Battle Mountain Gold gives Gold Standard Ventures another large project in one of Nevada's largest gold producing districts. More >

String of Positive Trial Results Boosts RepliCel's Profile
Source: The Life Sciences Report  (4/12/17)
Positive results from RepliCel's Phase 1 trial for the treatment of aging and sun-damaged skin follow the release in the past few weeks of positive data from trials for chronic tendon problems and for hair loss. More >

Five Companies with Favorable Risk/Reward Profiles from the AlphaNorth Capital Conference
Source: The Life Sciences Report  (4/12/17)
The 4th annual AlphaNorth Capital Conference brought together over 40 emerging growth companies with top investors. In this interview with Streetwise Reports, Steve Palmer, founder and president of AlphaNorth Asset Management and a co-organizer of the conference, discusses a diverse group of companies that were selected to attend the conference, including three biotech companies. More >

RXi Pharmaceuticals Receives Japanese Patent for RNAi Platform
Source: The Life Sciences Report  (4/12/17)
With the granting of a new patent in Japan for its lead compound, RXI-109, RXI Pharmaceuticals has strengthened its reach in Asian markets and enhanced the protections surrounding its proprietary RNAi platform. More >

Rye Patch Restarts Florida Canyon Mine
Source: The Gold Report  (4/11/17)
As iA Securities initiates coverage on Rye Patch, the miner receives state approval to start irrigation at the new pad at its Florida Canyon mine. More >

Trump's Missile Strike on Syria and Gold
Source: Clive Maund for The Gold Report  (4/11/17)
Technical analyst Clive Maund charts gold's movements following the U.S. missile attack on a Syrian airbase. More >

Trevali Mining Making All the Right Moves
Source: The Gold Report  (4/11/17)
Trevali keeps its eye on being THE "pure play" solution as it moves toward closing the agreement with Glencore International to acquire the Rosh Pinah and Perkoa zinc mines. More >

One Hour Alone with Rick Rule and It Finally Dawned on Me
Source: Daniel Ameduri for The Gold Report  (4/11/17)
Daniel Ameduri, cofounder of Future Money Trends, shares the insights into gold investing he gained from a conversation with veteran investor and money manager Rick Rule. More >

Charts Spelling 'Big Trouble' for Silver
Source: Clive Maund for The Gold Report  (4/11/17)
Silver's latest charts show that it is set up for a potentially severe decline, says technical analyst Clive Maund. More >

Doug Casey's Big Gold Play Makes 3,100% More than Gold Bullion
Source: Lior Gantz for The Gold Report  (4/9/17)
Lior Gantz of Wealth Resources Group discusses why he anticipates the majors will start making acquisitions of small-cap companies again and how investors can take advantage. More >

'Bond God' Jeff Gundlach Is Essentially Long Gold
Source: Tom Beck for The Gold Report  (4/9/17)
Tom Beck, senior editor of Portfolio Wealth Group, examines how low real interest rates boost gold. More >

Leagold Mining: Woodyer & Giustra Are Building Endeavour Mining 2.0
Source: The Critical Investor for The Gold Report  (4/9/17)
The Critical Investor profiles Leagold Mining, a company that just took over Goldcorp's Los Filos mine in Mexico. More >

Jack Chan’s Weekly Gold and Silver Update
Source: Jack Chan for The Gold Report  (4/8/17)
Technical analyst Jack Chan charts the latest developments in the gold and silver markets, including an all-time high in speculation in silver. More >

Integra Gold Is Entering Unicorn Territory
Source: The Gold Report  (4/6/17)
Companies tend to excel at exploration or development, but Integra Gold seems to do both well simultaneously. In this interview with The Gold Report, Integra CEO Stephen de Jong explains Integra's dual track, discusses the company's latest PEA and resource update, and enumerates Integra's path to production. More >

Permitting at NOVAGOLD's Donlin Project Is Entering Its Final Stage
Source: The Gold Report  (4/6/17)
The release of NOVAGOLD's first quarter results has analyst Raj Ray of National Bank Financial highlighting that permitting for the Donlin Gold project is entering its final stage. More >

Klondex Ups Mineral Resource at True North
Source: The Gold Report  (4/6/17)
An updated mineral resource for Klondex's True North project that increases the Measured and Indicated resource by 32% and the Inferred by 45% caught the attention of several analysts. More >

Pershing Gold Climbs to the Next Level in Nevada
Source: The Gold Report  (4/6/17)
As Pershing Gold closes a deal to consolidate its Blackjack project, it continues to move the Relief Canyon mine closer to production. More >

Four Biotech Mid-Caps Fund Manager Eden Rahim Believes Have Favorable Catalysts
Source: The Life Sciences Report  (4/5/17)
Biotech may be the last great bastion of stock picking, posits Eden Rahim, who manages the Toronto-based Next Edge Bio-Tech Plus Fund. The fund is up 40% in the last 12 months. In this interview with The Life Sciences Report, Rahim provides his view of the sector and profiles four companies he believes may have great upside. More >

VistaGen Therapeutics Advances New-Generation Antidepressant Approved by European Patent Office
Source: The Life Sciences Report  (4/5/17)
In a milestone for South San Francisco-based VistaGen Therapeutics, the European Patent Office (EPO) has issued a Notice of Intention to grant the company patents for its antidepressant prodrug, AV-101. More >

Cash-Rich Zynerba's Synthetic Cannabinoid Product Line Ready to Rumble
Source: The Life Sciences Report  (4/5/17)
Zynerba Pharmaceuticals specializes in developing and commercializing synthetic cannabinoid therapeutics formulated for transdermal delivery. The Devon, Pennsylvania-based company's Q4/16 financial results disclose a substantial cash kitty of ~$78M available to fund its pipeline of medical marijuana products, ZYN001 and ZYN002. More >

Buy Precious, Sell Base (Metals). . .
Source: Michael J. Ballanger for The Gold Report  (4/5/17)
Precious metals expert Michael Ballanger explains why he believes base metals are overbought and precious metals, especially silver, are set to appreciate. More >

Torchlight Energy Inks Drilling and Development Agreement with University Lands
Source: The Energy Report  (4/4/17)
An agreement that Torchlight Energy and its partner have signed with University Lands consolidates 192 existing leases in the Orogrande Basin project into one lease. More >

Checking In on Victoria Gold's 'Golden' Eagle Project
Source: The Gold Report  (4/4/17)
The Gold Report examined Victoria Gold's Eagle Project in February and is now checking in on the company's progress after two back-to-back news releases last week. More >